How does the dexamethasone (corticosteroid) suppression test work?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

How the Dexamethasone Suppression Test Works

The dexamethasone suppression test (DST) works by evaluating the negative feedback mechanism of the hypothalamic-pituitary-adrenal (HPA) axis by administering exogenous dexamethasone, which should suppress cortisol production in normal individuals but fails to do so in patients with Cushing's syndrome. 1

Basic Mechanism

  • The DST exploits the normal negative feedback mechanism where exogenous glucocorticoids (dexamethasone) should suppress ACTH production by the pituitary gland, leading to decreased cortisol secretion 2
  • In normal individuals, dexamethasone administration results in cortisol suppression below 1.8 μg/dL (50 nmol/L), indicating proper functioning of the HPA axis 1
  • In patients with Cushing's syndrome, this negative feedback mechanism is disrupted, resulting in failure to suppress cortisol production despite dexamethasone administration 2, 1

Types of Dexamethasone Suppression Tests

Overnight 1-mg DST

  • Patient takes 1 mg of dexamethasone orally at 11:00 PM, and serum cortisol is measured at 8:00 AM the following morning 1
  • Normal response: cortisol suppression to <1.8 μg/dL (50 nmol/L) 1, 3
  • Sensitivity of approximately 95% for detecting Cushing's syndrome 2
  • Particularly useful for ruling out dysregulated cortisol production from adrenal incidentalomas 1

2-Day Low-Dose DST (LDDST)

  • Dexamethasone is administered at 0.5 mg every 6 hours (09:00,15:00,21:00,03:00) for 48 hours 4
  • Cortisol measurements are taken at 0,24, and 48 hours 4
  • Normal response: cortisol suppression to <1.8 μg/dL (50 nmol/L) 1, 4
  • Sensitivity of 95% and specificity of 80% for diagnosing Cushing's syndrome 4

Factors Affecting Test Accuracy

  • False positive results (failure to suppress despite no Cushing's) can occur with:

    • Medications affecting dexamethasone metabolism (CYP3A4 inducers like phenobarbital, carbamazepine) 4, 5
    • Estrogen therapy (oral contraceptives) 2, 1
    • Rapid dexamethasone metabolism 1
    • Stress, depression, alcoholism, and severe obesity 2
  • False negative results (suppression despite Cushing's) can occur with:

    • Medications inhibiting dexamethasone metabolism (fluoxetine, cimetidine) 4
    • Decreased corticosteroid binding globulin (CBG) levels 1
    • Mild or cyclic Cushing's syndrome 6

Improving Test Accuracy

  • Measuring dexamethasone levels concomitantly with cortisol can reduce false-positive results 1, 7
  • The lower limit of normal dexamethasone concentration should be 1.8 ng/mL (4.6 nmol/L) 1
  • About 6% of non-Cushing's patients do not achieve adequate dexamethasone levels, which can lead to false-positive results 7

Clinical Pitfalls and Considerations

  • The DST should not be used as the sole criterion to exclude Cushing's syndrome, as some patients with confirmed disease may show suppression 6
  • The FDA warns that phenytoin, phenobarbital, ephedrine, and rifampin may enhance dexamethasone metabolism, potentially causing false-positive results 5
  • Indomethacin can cause false-negative results in the DST 5
  • For optimal diagnostic accuracy, the DST should be combined with other tests such as late-night salivary cortisol or 24-hour urinary free cortisol 2, 1

Diagnostic Algorithm

  • For patients with suspected Cushing's syndrome, start with either the overnight 1-mg DST, 24-hour urinary free cortisol, or late-night salivary cortisol 2, 1
  • If the initial test is abnormal, perform additional confirmatory tests 2
  • After confirming Cushing's syndrome, measure ACTH levels to determine if it is ACTH-dependent or ACTH-independent 2
  • For ACTH-dependent Cushing's, additional tests like pituitary MRI or inferior petrosal sinus sampling may be needed 2

References

Guideline

Diagnosing Cushing's Syndrome with Dexamethasone Suppression Test

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Interpretation of 2-Day LDDST Results

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

The low-dose dexamethasone suppression test: a reevaluation in patients with Cushing's syndrome.

The Journal of clinical endocrinology and metabolism, 2004

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.